Company / Current Assets
BioNexus Gene Lab Corp Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$5.4M
FY2025
5-year range
$5.4M / $8.0M
FY2021-FY2025
Trend
-26.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 7 years, ranging from $882,571 in FY2019 to $8M in FY2023.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of -7.4%.
Declined from $8M to $5M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -3.3%
- 5-Year CAGR
- -7.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -7.4%, indicating a declining trend.
- In FY2025, current assets decreased 26.7% year-over-year.
- Peak current assets was recorded in FY2023.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.4M | -26.7% |
| FY2024 | $7.4M | -7.7% |
| FY2023 | $8.0M | +33.6% |
| FY2022 | $6.0M | -15.8% |
| FY2021 | $7.1M | -10.5% |
| FY2020 | $8.0M | +804.8% |
| FY2019 | $882.6K | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026